Medicare Benefits Schedule - Item 14202

Search Results for Item 14202

View Associated Notes

Category 3 - THERAPEUTIC PROCEDURES

14202

14202 - Additional Information

Item Start Date:
01-Jul-2011
Description Updated:
01-Jul-2011
Schedule Fee Updated:
01-Jul-2021

Group
T1 - Miscellaneous Therapeutic Procedures
Subgroup
13 - Other Therapeutic Procedures

POLY-L-LACTIC ACID, one or more injections of (subsequent sessions), for the continuation of treatment of severe facial lipoatrophy caused by antiretroviral therapy, when prescribed in accordance with the National Health Act 1953

Fee: $124.75 Benefit: 75% = $93.60 85% = $106.05

(See para TN.1.16 of explanatory notes to this Category)

Extended Medicare Safety Net Cap: $18.75


Associated Notes

Category 3 - THERAPEUTIC PROCEDURES

TN.1.16

Facial Injections of Poly-L-Lactic Acid - (Items 14201 and 14202)

Poly-L-lactic acid is listed within the standard arrangements on the Pharmaceutical Benefits Scheme (PBS) as an Authority Required listing for initial and maintenance treatments, for facial administration only, of severe facial lipoatrophy caused by therapy for HIV infection.

Related Items: 14201 14202


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change